Standard Process Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Palmyra PA United States (1929)
Status: No NME R&D (1929)

Organization Overview

First Clinical Trial
2011
NCT01672359
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Standard Process Inc.